| Literature DB >> 34331697 |
Mohammad Amin Khodadadegan1, Shakiba Azami1, Paul C Guest2, Tannaz Jamialahmadi3,4, Amirhossein Sahebkar5,6,7,8.
Abstract
Depressive and anxiety disorders affect a significant proportion of the global population and constitute one of the highest disease burdens worldwide. Conventional pharmacological treatments are traditionally the first line of therapy for individuals affected by these conditions although these are only successful approximately half of the time and are often associated with undesirable side effects. This review describes the use of the natural substance curcumin as a potential alternative treatment of these mental disorders. With this in mind, we analyzed the effects of curcumin in eight clinical studies of depression and five studies of anxiety and assessed these using psychiatric symptom scores and molecular biomarker readouts.Entities:
Keywords: Add-on treatment; Antidepressant; Anxiety; Axiolytic; Curcumin; Depression; MDD; Therapy
Mesh:
Substances:
Year: 2021 PMID: 34331697 DOI: 10.1007/978-3-030-56153-6_17
Source DB: PubMed Journal: Adv Exp Med Biol ISSN: 0065-2598 Impact factor: 2.622